glp-1 hub podcast On The Pen News Dark side of GLP-1 meds

4 Clinical evidence in T2DM management A wide range of clinical trials and research have been performed to assess the effectiveness, safety, and tolerability of short-acting against long-acting GLP-1 analogues in the treatment and management of T2DM and obesity

Germline stem cells and their regulation in the nematode Caenorhabditis elegans

Q: Will I never enjoy a favorite meal again if I take this

2 There is a theoretical risk of medullary carcinoma of the thyroid due to the GLP-1-mediated effect of calcitonin release

The CDMO capacity that exists for complex peptide manufacturing in 2026 is more constrained than any other segment of the pharmaceutical contract manufacturing market

Semaglutide (Ozempic, Wegovy) has a half-life of approximately 7 days and takes about 5 weeks (five half-lives) for 97% clearance from the body after the final injection